Villya Announces Breakthrough Data Demonstrating Enhanced Stability and Solubility for Insulin, GLP-1s
Novel oral peptide delivery platform demonstrates preservation of semaglutide and insulin integrity after prolonged exposure to simulated gastric conditions MELBOURNE, FL, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- Villya Announces Breakthrough …